Author:
Moliva Juan I.,Hossfeld Austin P.,Sidiki Sabeen,Canan Cynthia H.,Dwivedi Varun,Beamer Gillian,Turner Joanne,Torrelles Jordi B.
Publisher
Springer Science and Business Media LLC
Subject
Immunology,Immunology and Allergy
Reference49 articles.
1. WHO. Global Tuberculosis Report 2018. pp. 1–277. (WHO Organization, Geneva, 2018).
http://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1
.
2. Moliva, J. I., Turner, J. & Torrelles, J. B. Prospects in Mycobacterium bovis Bacille Calmette et Guerin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis? Vaccine 33, 5035–5041 (2015).
3. Moliva, J. I., Turner, J. & Torrelles, J. B. Immune responses to BCG vaccination: why do they fail to protect against Mycobacterium tuberculosis? Front Immunol. 8, 407 (2017).
4. Lambert, P. H. & Laurent, P. E. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine 26, 3197–3208 (2008).
5. Derrick, S. C., Kolibab, K., Yang, A. & Morris, S. L. Intranasal administration of Mycobacterium bovis BCG induces superior protection against aerosol infection with Mycobacterium tuberculosis in mice. Clin. Vaccin. Immunol. 21, 1443–1451 (2014).